首页> 外国专利> USE OF EXTRACT OR FRACTION OF OPHIOCORDYCEPS IN MANUFACTURE OF MEDICAMENT FOR TREATMENT OF SLEEPING DISORDER

USE OF EXTRACT OR FRACTION OF OPHIOCORDYCEPS IN MANUFACTURE OF MEDICAMENT FOR TREATMENT OF SLEEPING DISORDER

机译:提取和纯化鞘膜念珠菌在治疗睡眠障碍的药物中的应用

摘要

A use of an extract or fraction, derivative or chemically synthesized or modified form of any one or more components of Ophiocordyceps or a genetically modified or phenotypically adapted strain thereof in manufacture of a medicament for treatment a sleeping disorder and the like is provided. A method for treating human subject with a cortisol-based disorder or condition or with the potential for deveploping a cortisol-based disorder or condition is also provided. A system for treating sleep apnea or snoring in a subject is provided comprising an extract or fraction, derivative of Ophiocordyceps or a genetically modified or phenotypically adapted strain thereof or chemically synthesized or modified form of any one or more components.
机译:提供了麦兜菌属或其遗传修饰或表型适应性菌株的任何一种或多种组分的提取物或级分,衍生物或化学合成或修饰形式在制备用于治疗睡眠障碍等的药物中的用途。还提供了一种用于治疗患有基于皮质醇的病症或病状或具有发展基于皮质醇的病症或病状的潜力的人类受试者的方法。提供了一种用于治疗受试者的睡眠呼吸暂停或打呼nor的系统,其包含麦兜球菌或其基因修饰或表型适应菌株的提取物或级分,衍生物,或任何一种或多种成分的化学合成或修饰形式。

著录项

  • 公开/公告号WO2015092538A1

    专利类型

  • 公开/公告日2015-06-25

    原文格式PDF

  • 申请/专利权人 MAXGROUP RIGHTS HOLDINGS LTD;

    申请/专利号WO2014IB02964

  • 发明设计人 BENNETT ILYA;

    申请日2014-12-18

  • 分类号A61K36/068;A61P9;A61P9/04;A61P11;A61P25/08;A61P25/24;A61P25/28;

  • 国家 WO

  • 入库时间 2022-08-21 15:05:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号